MCID: GLL048
MIFTS: 45

Glial Tumor

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Glial Tumor

MalaCards integrated aliases for Glial Tumor:

Name: Glial Tumor 58
Glioma 58

Characteristics:

Orphanet epidemiological data:

58
glial tumor
Prevalence: 1-9/100000 (United States),1-5/10000 (Europe);

Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

MESH via Orphanet 44 D005910
UMLS via Orphanet 72 C0017638
Orphanet 58 ORPHA182067

Summaries for Glial Tumor

MalaCards based summary : Glial Tumor, also known as glioma, is related to childhood brain stem glioma and brain stem glioma. An important gene associated with Glial Tumor is IDH1 (Isocitrate Dehydrogenase (NADP(+)) 1), and among its related pathways/superpathways are Glucose / Energy Metabolism and Central carbon metabolism in cancer. The drugs Midazolam and Dexmedetomidine have been mentioned in the context of this disorder. Affiliated tissues include brain, t cells and endothelial, and related phenotypes are growth/size/body region and respiratory system

Wikipedia : 74 Glial tumor is a general term for numerous tumors of the central nervous system (CNS), including... more...

Related Diseases for Glial Tumor

Diseases related to Glial Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1111, show less)
# Related Disease Score Top Affiliating Genes
1 childhood brain stem glioma 33.8 OLIG2 IDH1
2 brain stem glioma 33.3 PTEN OLIG2 IDH1
3 mixed oligodendroglioma-astrocytoma 32.1 PTEN IDH1
4 glioma susceptibility 1 31.7 PTEN OLIG2 IDH1
5 medulloblastoma 31.2 PTEN MMP9 IDH1
6 glioma 30.4 PTEN MMP9 IDH1
7 dysembryoplastic neuroepithelial tumor 30.2 OLIG2 IDH1
8 arteriovenous malformation 30.1 PTEN MMP9
9 glioblastoma multiforme 30.0 PTEN MMP9 IDH1
10 oligodendroglioma 30.0 PTEN OLIG2 IDH1
11 li-fraumeni syndrome 30.0 PTEN IDH1
12 childhood oligodendroglioma 29.8 OLIG2 IDH1
13 supratentorial cancer 29.8 OLIG2 IDH1
14 high-grade astrocytoma 29.8 PTEN IDH1
15 brain stem cancer 29.7 OLIG2 IDH1
16 central nervous system cancer 29.7 PTEN OLIG2 IDH1
17 brain glioma 29.6 PTEN IDH1
18 hemangioma 29.6 PTEN MMP9 IDH1
19 giant cell glioblastoma 29.6 PTEN OLIG2 IDH1
20 gemistocytic astrocytoma 29.5 PTEN IDH1
21 gliomatosis cerebri 29.5 PTEN IDH1
22 mixed glioma 29.4 PTEN OLIG2 IDH1
23 juvenile pilocytic astrocytoma 29.4 PTEN OLIG2 IDH1
24 clear cell ependymoma 29.4 OLIG2 IDH1
25 supratentorial primitive neuroectodermal tumor 29.4 OLIG2 IDH1
26 skin melanoma 29.4 PTEN MMP9
27 brain cancer 29.4 PTEN OLIG2 IDH1
28 grade iii astrocytoma 29.3 PTEN OLIG2 MMP9 IDH1
29 leukemia, acute myeloid 29.3 PTEN MMP9 IDH1
30 lung cancer susceptibility 3 29.3 PTEN MMP9 IDH1
31 intrahepatic cholangiocarcinoma 29.3 PTEN MMP9 IDH1
32 fibrillary astrocytoma 29.2 PTEN OLIG2 IDH1
33 benign giant cell tumor 29.2 MMP9 CA2
34 myeloma, multiple 29.1 PTEN MMP9 IDH1
35 myelodysplastic syndrome 29.0 PTEN MMP9 IDH1
36 clear cell renal cell carcinoma 28.9 PTEN MMP9 IDH1
37 gastric adenocarcinoma 28.8 PTEN MMP9 IDH1
38 gliosarcoma 28.8 PTEN OLIG2 MMP9 IDH1
39 spinal disease 28.8 PTEN OLIG2 IDH1
40 osteoporosis 27.7 PTEN MMP9 CA2
41 optic nerve glioma 12.6
42 glioma susceptibility 9 12.6
43 glioma susceptibility 3 12.6
44 optic pathway glioma 12.5
45 glioma susceptibility 2 12.5
46 mixed neuronal-glial tumor 12.5
47 diffuse midline glioma, h3 k27m-mutant 12.4
48 subependymal glioma 12.3
49 glial tumor of neuroepithelial tissue with unknown origin 12.3
50 childhood optic nerve glioma 12.3
51 glioma susceptibility 6 12.3
52 glioma susceptibility 8 12.3
53 glioma susceptibility 5 12.3
54 glioma susceptibility 7 12.3
55 glioma susceptibility 4 12.2
56 adult brain stem glioma 12.2
57 adult brainstem mixed glioma 12.2
58 visual pathway and hypothalamic glioma, childhood 12.1
59 mismatch repair cancer syndrome 12.1
60 limbic encephalitis with lgi1 antibodies 12.0
61 neurofibromatosis, type i 11.7
62 astroblastoma 11.7
63 encephalocraniocutaneous lipomatosis 11.6
64 anaplastic oligodendroglioma 11.5
65 rosette-forming glioneuronal tumor 11.5
66 nasal glial heterotopia 11.5
67 spinal cord glioma 11.5
68 subependymoma 11.4
69 pituicytoma 11.4
70 brain glioblastoma multiforme 11.4
71 brain stem astrocytic neoplasm 11.4
72 osteoporosis-pseudoglioma syndrome 11.4
73 brain oligodendroglioma 11.4
74 legius syndrome 11.3
75 neurofibromatosis-noonan syndrome 11.2
76 nijmegen breakage syndrome 11.1
77 chromosome 17q11.2 deletion syndrome 11.1
78 spinal cord ependymoma 11.1
79 brain stem ependymoma 11.1
80 brain ependymoma 11.1
81 temporal epilepsy, familial 11.1
82 hydrocephalus 10.7
83 hypoxia 10.6
84 astrocytoma 10.6
85 pertussis 10.6
86 severe combined immunodeficiency 10.5
87 b-cell lymphoma 10.5
88 lymphopenia 10.4
89 epilepsy 10.4
90 aphasia 10.4
91 cytokine deficiency 10.4
92 exophthalmos 10.4
93 exanthem 10.3
94 lymphoma 10.3
95 pulmonary embolism 10.3
96 rare tumor 10.3
97 malignant glioma 10.3
98 central nervous system lymphoma 10.3
99 sarcoma 10.3
100 spindle cell sarcoma 10.3
101 obstructive hydrocephalus 10.3
102 limbic encephalitis 10.3
103 precocious puberty 10.3
104 primary central nervous system lymphoma 10.3
105 osteogenic sarcoma 10.3
106 yemenite deaf-blind hypopigmentation syndrome 10.3
107 temporal lobe epilepsy 10.3
108 headache 10.3
109 pathologic nystagmus 10.2
110 hemiplegia 10.2
111 craniopharyngioma 10.2
112 encephalocele 10.2
113 ataxia-telangiectasia 10.2
114 leukemia 10.2
115 telangiectasis 10.2
116 neuropathy 10.2
117 diencephalic syndrome 10.2
118 benign ependymoma 10.2
119 ganglioglioma 10.2
120 cellular ependymoma 10.2
121 bladder cancer 10.2
122 3-methylglutaconic aciduria, type iii 10.2
123 demyelinating disease 10.2
124 ependymoblastoma 10.2
125 meningioma, radiation-induced 10.2
126 meningioma, familial 10.2
127 spinal meningioma 10.2
128 secretory meningioma 10.2
129 lymphoplasmacyte-rich meningioma 10.2
130 acoustic neuroma 10.2
131 vaccinia 10.2
132 measles 10.2
133 diabetes insipidus 10.2
134 triiodothyronine receptor auxiliary protein 10.2
135 li-fraumeni syndrome 2 10.2
136 allergic hypersensitivity disease 10.2
137 constipation 10.2
138 newcastle disease 10.2
139 alopecia 10.2
140 colorectal cancer 10.2
141 peripheral nervous system disease 10.2
142 stomatitis 10.2
143 specific language disorder 10.2
144 dermatitis 10.2
145 autoimmune encephalitis 10.2
146 encephalopathy 10.2
147 multiple sclerosis 10.1
148 wilms tumor 1 10.1
149 neuroma 10.1
150 teratoma 10.1
151 strabismus 10.1
152 tumor predisposition syndrome 10.1
153 mucositis 10.1
154 diphtheria 10.1
155 neuritis 10.1
156 mechanical strabismus 10.1
157 pheochromocytoma 10.1
158 lung cancer 10.1
159 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
160 status epilepticus 10.1
161 dysphagia 10.1
162 oligoastrocytoma 10.1
163 alzheimer disease 10.1
164 autoimmune disease 10.1
165 adrenal gland pheochromocytoma 10.1
166 apraxia 10.1
167 adenocarcinoma 10.1
168 rhabdomyosarcoma 10.1
169 paraplegia 10.1
170 herpes zoster 10.1
171 chickenpox 10.1
172 chromosomal triplication 10.1
173 depression 10.1
174 head injury 10.1
175 thyroid carcinoma 10.1
176 adult oligodendroglioma 10.1 OLIG2 IDH1
177 optic neuritis 10.1
178 cytomegalovirus infection 10.1
179 tuberous sclerosis 10.1
180 low-grade astrocytoma 10.1
181 cerebrum cancer 10.0 OLIG2 IDH1
182 hand skill, relative 10.0
183 prostate cancer 10.0
184 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
185 melanoma, cutaneous malignant 10 10.0
186 tatton-brown-rahman syndrome 10.0
187 hypothyroidism 10.0
188 optic nerve disease 10.0
189 cranial nerve palsy 10.0
190 central precocious puberty 10.0
191 overgrowth syndrome 10.0
192 cerebral ventricle cancer 10.0 OLIG2 IDH1
193 ocular motor apraxia 10.0
194 familial adenomatous polyposis 10.0
195 papilledema 10.0
196 mental depression 10.0
197 hypogonadism 10.0
198 tic disorder 10.0
199 fibrosarcoma 10.0
200 nominal aphasia 10.0
201 progressive multifocal leukoencephalopathy 10.0
202 myeloid leukemia 10.0
203 aneurysm 10.0
204 posttransplant acute limbic encephalitis 10.0
205 pik3ca-related overgrowth syndrome 10.0
206 breast duct papilloma 10.0 PTEN IDH1
207 neurilemmoma 10.0
208 neuroblastoma 10.0
209 amyotrophic lateral sclerosis 1 10.0
210 renal cell carcinoma, nonpapillary 10.0
211 ige responsiveness, atopic 10.0
212 small cell cancer of the lung 10.0
213 fanconi anemia, complementation group d2 10.0
214 proteasome-associated autoinflammatory syndrome 1 10.0
215 pancreatic cancer 10.0
216 retinitis pigmentosa 11 10.0
217 allergic rhinitis 10.0
218 major depressive disorder 10.0
219 rhabdoid tumor predisposition syndrome 1 10.0
220 hypophosphatemia 10.0
221 ptosis 10.0
222 lateral sclerosis 10.0
223 mood disorder 10.0
224 rhabdoid cancer 10.0
225 thrombophlebitis 10.0
226 dysgraphia 10.0
227 meningitis 10.0
228 granulocytopenia 10.0
229 cerebral aneurysms 10.0
230 traumatic brain injury 10.0
231 adult astrocytic tumour 10.0 PTEN IDH1
232 polykaryocytosis inducer 10.0
233 sarcoidosis 1 10.0
234 syringomyelia, noncommunicating isolated 10.0
235 subacute sclerosing panencephalitis 10.0
236 xeroderma pigmentosum, variant type 10.0
237 body mass index quantitative trait locus 1 10.0
238 mutagen sensitivity 10.0
239 acute promyelocytic leukemia 10.0
240 gastric cancer 10.0
241 pollen allergy 10.0
242 amnestic disorder 10.0
243 respiratory failure 10.0
244 squamous cell papilloma 10.0
245 facial paralysis 10.0
246 central neurocytoma 10.0
247 communicating hydrocephalus 10.0
248 squamous cell carcinoma 10.0
249 atypical teratoid rhabdoid tumor 10.0
250 papilloma 10.0
251 severe acute respiratory syndrome 10.0
252 syringomyelia 10.0
253 germinoma 10.0
254 benign meningioma 10.0
255 pituitary gland disease 10.0
256 dystonia 10.0
257 cerebrovascular disease 10.0
258 hypopituitarism 10.0
259 allergic encephalomyelitis 10.0
260 dentinogenesis imperfecta type 2 10.0
261 growth hormone deficiency 10.0
262 herpes simplex encephalitis 10.0
263 cerebrofacial arteriovenous metameric syndrome 10.0
264 spasmus nutans 10.0
265 benign idiopathic neonatal seizures 10.0
266 malignant ependymoma 9.9
267 papillary glioneuronal tumors 9.9
268 uterine corpus endometrial carcinoma 9.9 PTEN IDH1
269 burkitt lymphoma 9.9
270 seizures, benign familial neonatal, 1 9.9
271 esophageal cancer 9.9
272 migraine with or without aura 1 9.9
273 chordoma 9.9
274 spondylometaphyseal dysplasia, sedaghatian type 9.9
275 pituitary hormone deficiency, combined, 2 9.9
276 autism x-linked 2 9.9
277 nasopharyngeal carcinoma 9.9
278 cholangiocarcinoma 9.9
279 speech and communication disorders 9.9
280 diffuse large b-cell lymphoma 9.9
281 agraphia 9.9
282 thrombosis 9.9
283 benign teratoma 9.9
284 cysticercosis 9.9
285 meningoencephalitis 9.9
286 neurosarcoidosis 9.9
287 alexia 9.9
288 amenorrhea 9.9
289 vascular disease 9.9
290 benign mesothelioma 9.9
291 cystic teratoma 9.9
292 plasmacytoma 9.9
293 pilocytic astrocytoma of cerebellum 9.9
294 mature teratoma 9.9
295 thyroid hyalinizing trabecular adenoma 9.9
296 autosomal dominant epilepsy with auditory features 9.9
297 germ cells tumors 9.9
298 anoxia 9.9
299 cerebral atrophy 9.9
300 argyria 9.9
301 polyploidy 9.9
302 bile duct adenocarcinoma 9.9 PTEN IDH1
303 verrucous carcinoma 9.9 PTEN MMP9
304 hair whorl 9.9
305 lipomatosis, multiple 9.9
306 parkinson disease, late-onset 9.9
307 torticollis 9.9
308 down syndrome 9.9
309 suppressor of tumorigenicity 3 9.9
310 alexander disease 9.9
311 chondrosarcoma 9.9
312 fanconi anemia, complementation group a 9.9
313 hydrocephalus due to congenital stenosis of aqueduct of sylvius 9.9
314 papilloma of choroid plexus 9.9
315 kearns-sayre syndrome 9.9
316 mycobacterium tuberculosis 1 9.9
317 intraocular pressure quantitative trait locus 9.9
318 major affective disorder 8 9.9
319 major affective disorder 9 9.9
320 peroxisome biogenesis disorder 10a 9.9
321 leukemia, acute lymphoblastic 3 9.9
322 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.9
323 aspiration pneumonia 9.9
324 scoliosis 9.9
325 pleomorphic lipoma 9.9
326 rabies 9.9
327 pulmonary edema 9.9
328 lymphocytic choriomeningitis 9.9
329 pancytopenia 9.9
330 acute leukemia 9.9
331 diarrhea 9.9
332 myelitis 9.9
333 bipolar disorder 9.9
334 mesenchymal cell neoplasm 9.9
335 pulmonary fibrosis 9.9
336 hypokalemia 9.9
337 gerstmann syndrome 9.9
338 chordoid meningioma 9.9
339 nervous system disease 9.9
340 vasculitis 9.9
341 tetraploidy 9.9
342 myoclonus 9.9
343 cat eye syndrome 9.9
344 retinoblastoma 9.9
345 tuberous sclerosis 1 9.9
346 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.9
347 alpha-thalassemia 9.9
348 hydrops, lactic acidosis, and sideroblastic anemia 9.9
349 thalassemia 9.9
350 visual epilepsy 9.9
351 cholera 9.9
352 hyperglycemia 9.9
353 familial retinoblastoma 9.9
354 pleomorphic xanthoastrocytoma 9.9
355 subependymal giant cell astrocytoma 9.9
356 anaplastic oligoastrocytoma 9.9
357 seizure disorder 9.9
358 tongue disease 9.8 PTEN MMP9
359 ductal carcinoma in situ 9.8 PTEN MMP9
360 alcohol dependence 9.8
361 epidermoid cysts 9.8
362 erythroleukemia, familial 9.8
363 hemifacial spasm, familial 9.8
364 hypertriglyceridemia, familial 9.8
365 enchondromatosis, multiple, ollier type 9.8
366 otitis media 9.8
367 schizophrenia 9.8
368 spinal arachnoiditis 9.8
369 arachnoid cysts, intracranial 9.8
370 maple syrup urine disease 9.8
371 moyamoya disease 1 9.8
372 nonarteritic anterior ischemic optic neuropathy 9.8
373 thrombocytopenia 3 9.8
374 thymoma, familial 9.8
375 xeroderma pigmentosum, complementation group f 9.8
376 aging 9.8
377 branchiootic syndrome 1 9.8
378 cervical cancer 9.8
379 migraine with or without aura 3 9.8
380 leukemia, chronic myeloid 9.8
381 thrombocytopenia 4 9.8
382 alacrima, achalasia, and mental retardation syndrome 9.8
383 hyperprolactinemia 9.8
384 inflammatory bowel disease 9.8
385 sleep apnea 9.8
386 cerebellar hypoplasia 9.8
387 intracranial abscess 9.8
388 neuroretinitis 9.8
389 suppression amblyopia 9.8
390 amblyopia 9.8
391 leukodystrophy 9.8
392 microphthalmia 9.8
393 microcephaly 9.8
394 intracranial aneurysm 9.8
395 alternating exotropia 9.8
396 exotropia 9.8
397 arachnoiditis 9.8
398 anisometropia 9.8
399 pineoblastoma 9.8
400 hyperinsulinism 9.8
401 lipomatosis 9.8
402 ischemia 9.8
403 thymoma 9.8
404 skin carcinoma 9.8
405 breast adenocarcinoma 9.8
406 retinitis 9.8
407 lactic acidosis 9.8
408 pancreatic adenocarcinoma 9.8
409 myopathy 9.8
410 akinetic mutism 9.8
411 tinea capitis 9.8
412 macular retinal edema 9.8
413 rhinitis 9.8
414 movement disease 9.8
415 plexiform neurofibroma 9.8
416 pneumonia 9.8
417 hemolytic anemia 9.8
418 malignant peripheral nerve sheath tumor 9.8
419 parasagittal meningioma 9.8
420 protoplasmic astrocytoma 9.8
421 dermatophytosis 9.8
422 diabetes mellitus 9.8
423 bacterial meningitis 9.8
424 hypereosinophilic syndrome 9.8
425 anaplastic pleomorphic xanthoastrocytoma 9.8
426 cerebrospinal fluid leak 9.8
427 chiari malformation 9.8
428 splenomegaly 9.8
429 hemifacial spasm 9.8
430 spasticity 9.8
431 syncope 9.8
432 monosomy 22 9.8
433 refractory anemia 9.8
434 non-alcoholic steatohepatitis 9.8 PTEN MMP9
435 colorectal adenocarcinoma 9.8 PTEN MMP9
436 abducens palsy 9.7
437 pfeiffer syndrome 9.7
438 sotos syndrome 1 9.7
439 fibrodysplasia ossificans progressiva 9.7
440 fibrosis of extraocular muscles, congenital, 1 9.7
441 huntington disease 9.7
442 kaposi sarcoma 9.7
443 keratitis, hereditary 9.7
444 leukemia, chronic lymphocytic 9.7
445 systemic lupus erythematosus 9.7
446 nevus, epidermal 9.7
447 obsessive-compulsive disorder 9.7
448 optic atrophy 1 9.7
449 teratoma, ovarian 9.7
450 paragangliomas 1 9.7
451 thrombocytopenia 2 9.7
452 digeorge syndrome 9.7
453 thyroid cancer, nonmedullary, 1 9.7
454 trigeminal neuralgia 9.7
455 vitiligo-associated multiple autoimmune disease susceptibility 6 9.7
456 von hippel-lindau syndrome 9.7
457 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 9.7
458 fructose utilization 9.7
459 hemangiopericytoma, malignant 9.7
460 lymphoma, hodgkin, classic 9.7
461 krabbe disease 9.7
462 myelofibrosis 9.7
463 lesch-nyhan syndrome 9.7
464 thrombocytopenia 1 9.7
465 oncocytoma 9.7
466 epilepsy, familial temporal lobe, 1 9.7
467 stroke, ischemic 9.7
468 renal cell carcinoma, papillary, 1 9.7
469 early response to neural induction gene 9.7
470 vitiligo-associated multiple autoimmune disease susceptibility 1 9.7
471 anorexia nervosa 9.7
472 mandibuloacral dysplasia with type b lipodystrophy 9.7
473 aspergillosis 9.7
474 myopathy, distal, tateyama type 9.7
475 multiple enchondromatosis, maffucci type 9.7
476 diarrhea 6 9.7
477 pachyonychia congenita 3 9.7
478 joint laxity, short stature, and myopia 9.7
479 chronic diarrhea due to guanylate cyclase 2c overactivity 9.7
480 mantle cell lymphoma 9.7
481 arteritic anterior ischemic optic neuropathy 9.7
482 autism spectrum disorder 9.7
483 estrogen-receptor positive breast cancer 9.7
484 generalized epilepsy with febrile seizures plus 9.7
485 cardiac arrest 9.7
486 respiratory allergy 9.7
487 drug allergy 9.7
488 lymphoproliferative syndrome 9.7
489 polycystic kidney disease 9.7
490 migraine with aura 9.7
491 cerebral artery occlusion 9.7
492 osteomyelitis 9.7
493 monocular esotropia 9.7
494 interstitial nephritis 9.7
495 premature menopause 9.7
496 meningocele 9.7
497 tetanus 9.7
498 pneumocystosis 9.7
499 myopia 9.7
500 cryptococcosis 9.7
501 bronchopneumonia 9.7
502 locked-in syndrome 9.7
503 guillain-barre syndrome 9.7
504 transient global amnesia 9.7
505 uveitis 9.7
506 beriberi 9.7
507 foster-kennedy syndrome 9.7
508 panniculitis 9.7
509 urticaria 9.7
510 normal pressure hydrocephalus 9.7
511 retinal vein occlusion 9.7
512 encephalomalacia 9.7
513 thrombocytosis 9.7
514 colon adenocarcinoma 9.7
515 relapsing-remitting multiple sclerosis 9.7
516 central retinal vein occlusion 9.7
517 psychotic disorder 9.7
518 sensory peripheral neuropathy 9.7
519 basal cell carcinoma 9.7
520 reflex epilepsy 9.7
521 chondroma 9.7
522 laryngeal squamous cell carcinoma 9.7
523 cervix carcinoma 9.7
524 pulmonary tuberculosis 9.7
525 testicular cancer 9.7
526 acute kidney failure 9.7
527 juvenile astrocytoma 9.7
528 embryonal carcinoma 9.7
529 central nervous system disease 9.7
530 plague 9.7
531 pancreatic ductal adenocarcinoma 9.7
532 choriocarcinoma 9.7
533 lynch syndrome 9.7
534 differentiating neuroblastoma 9.7
535 dyslexia 9.7
536 microcystic meningioma 9.7
537 ideomotor apraxia 9.7
538 embryoma 9.7
539 cavernous hemangioma 9.7
540 gliofibroma 9.7
541 poliomyelitis 9.7
542 rhabdoid meningioma 9.7
543 ovarian cyst 9.7
544 infertility 9.7
545 sleep disorder 9.7
546 internuclear ophthalmoplegia 9.7
547 scrapie 9.7
548 ovarian germ cell teratoma 9.7
549 kidney disease 9.7
550 spinal cancer 9.7
551 optic nerve sheath meningioma 9.7
552 cerebral lymphoma 9.7
553 congestive heart failure 9.7
554 cerebral meningioma 9.7
555 conjunctivitis 9.7
556 viral encephalitis 9.7
557 prion disease 9.7
558 anthrax disease 9.7
559 myocarditis 9.7
560 cataract 9.7
561 lung disease 9.7
562 ulcerative colitis 9.7
563 rosacea 9.7
564 autosomal dominant polycystic kidney disease 9.7
565 scotoma 9.7
566 blepharitis 9.7
567 esotropia 9.7
568 toxoplasmosis 9.7
569 ankrd26-related thrombocytopenia 9.7
570 trichorhinophalangeal syndrome 9.7
571 chromophil renal cell carcinoma 9.7
572 embryonal sarcoma 9.7
573 gigantism 9.7
574 meningoencephalocele 9.7
575 trichothiodystrophy 9.7
576 triploidy 9.7
577 tuberculous meningitis 9.7
578 weber syndrome 9.7
579 cav3-related distal myopathy 9.7
580 back pain 9.7
581 brain injury 9.7
582 febrile seizures 9.7
583 paresthesia 9.7
584 supernumerary breasts 9.7
585 nasal encephalocele 9.7
586 cebpe-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome 9.7
587 rela fusion-positive ependymoma 9.7
588 histiocytic sarcoma 9.7
589 premature aging 9.7
590 rare epilepsy 9.7
591 breast cancer 9.7
592 hepatocellular carcinoma 9.7
593 ovarian cancer 9.7
594 multiple endocrine neoplasia, type iia 9.7
595 porphyria, acute intermittent 9.7
596 retinal detachment 9.7
597 thrombophilia due to thrombin defect 9.7
598 leukoencephalopathy, hereditary diffuse, with spheroids 9.7
599 hydrocephalus, congenital, 1 9.7
600 immune deficiency disease 9.7
601 insulin-like growth factor i 9.7
602 coats disease 9.7
603 alpha-thalassemia/mental retardation syndrome, x-linked 9.7
604 ataxia and polyneuropathy, adult-onset 9.7
605 wilms tumor 5 9.7
606 gastrointestinal stromal tumor 9.7
607 endometrial cancer 9.7
608 leukemia, acute lymphoblastic 9.7
609 helix syndrome 9.7
610 cerebellar medulloblastoma 9.7
611 brain meningioma 9.7
612 covid-19 9.7
613 blind hypotensive eye 9.7
614 neutropenia 9.7
615 porphyria 9.7
616 thrombocytopenia 9.7
617 neovascular glaucoma 9.7
618 melanoma 9.7
619 focal epilepsy 9.7
620 gangliocytoma 9.7
621 kidney cancer 9.7
622 multiple endocrine neoplasia 9.7
623 histiocytosis 9.7
624 mast cell neoplasm 9.7
625 third ventricle chordoid glioma 9.7
626 chordoid glioma 9.7
627 pituitary adenoma 9.7
628 mutism 9.7
629 erdheim-chester disease 9.7
630 extracutaneous mastocytoma 9.7
631 brain edema 9.7
632 ganglioneuroma 9.7
633 pilomyxoid astrocytoma 9.7
634 cerebellar astrocytoma 9.7
635 myxopapillary ependymoma 9.7
636 hemangioblastoma 9.7
637 human immunodeficiency virus infectious disease 9.7
638 pediatric ependymoma 9.7
639 acquired immunodeficiency syndrome 9.7
640 adenoma 9.7
641 herpes simplex 9.7
642 neurofibromatosis 9.7
643 speech disorder 9.7
644 intracranial hypertension 9.7
645 encephalitis 9.7
646 neurofibroma 9.7
647 hypoglycemia 9.7
648 47,xyy 9.7
649 48,xyyy 9.7
650 anaplastic ependymoma 9.7
651 anaplastic ganglioglioma 9.7
652 brain tumor, childhood 9.7
653 desmoplastic infantile astrocytoma 9.7
654 desmoplastic infantile ganglioglioma 9.7
655 angiomatosis 9.7
656 cavernous malformation 9.7
657 pituitary tumors 9.7
658 spinal cord injury 9.7
659 tremor 9.7
660 rapidly involuting congenital hemangioma 9.7
661 angiocentric glioma 9.7
662 neuronal tumor 9.7
663 thyroid tumor 9.7
664 ocular hypertension 9.6 PTEN CA2
665 central nervous system benign neoplasm 9.6 PTEN OLIG2 IDH1
666 infratentorial cancer 9.6 PTEN OLIG2 IDH1
667 suppression of tumorigenicity 12 9.6 PTEN MMP9 IDH1
668 neurofibromatosis, type ii 9.6
669 cerebral amyloid angiopathy, cst3-related 9.6
670 arteriovenous malformations of the brain 9.6
671 gastroesophageal reflux 9.6
672 branchiooculofacial syndrome 9.6
673 progressive familial heart block, type ia 9.6
674 cerebral cavernous malformations 9.6
675 charcot-marie-tooth disease, demyelinating, type 1a 9.6
676 van der woude syndrome 1 9.6
677 cleft palate, isolated 9.6
678 creutzfeldt-jakob disease 9.6
679 deafness, unilateral 9.6
680 episodic kinesigenic dyskinesia 1 9.6
681 beckwith-wiedemann syndrome 9.6
682 multiple endocrine neoplasia, type i 9.6
683 exostoses, multiple, type i 9.6
684 exostoses, multiple, type ii 9.6
685 renal cysts and diabetes syndrome 9.6
686 hypercholesterolemia, familial, 1 9.6
687 hypertelorism 9.6
688 hypertension, essential 9.6
689 immunoglobulin switch sequences 9.6
690 intussusception 9.6
691 klippel-trenaunay-weber syndrome 9.6
692 lentigines 9.6
693 melanoma, uveal 9.6
694 melanoma-astrocytoma syndrome 9.6
695 antigen defined by monoclonal antibody aj9 9.6
696 nondisjunction 9.6
697 myelopathy, htlv-1-associated 9.6
698 episodic ataxia, type 1 9.6
699 noonan syndrome 1 9.6
700 oculodentodigital dysplasia 9.6
701 familial adenomatous polyposis 1 9.6
702 greig cephalopolysyndactyly syndrome 9.6
703 pulmonary fibrosis, idiopathic 9.6
704 retinitis pigmentosa 10 9.6
705 schistosoma mansoni infection, susceptibility/ 9.6
706 schizophrenia 1 9.6
707 odontochondrodysplasia 9.6
708 sturge-weber syndrome 9.6
709 wolf-hirschhorn syndrome 9.6
710 zinc finger protein 1 9.6
711 autism 9.6
712 cystic fibrosis 9.6
713 dyssegmental dysplasia, rolland-desbuquois type 9.6
714 factor vii deficiency 9.6
715 galactorrhea 9.6
716 hydatidiform mole, recurrent, 1 9.6
717 multiple acyl-coa dehydrogenase deficiency 9.6
718 hemochromatosis, type 1 9.6
719 l-2-hydroxyglutaric aciduria 9.6
720 marinesco-sjogren syndrome 9.6
721 microcephaly 1, primary, autosomal recessive 9.6
722 mucolipidosis iv 9.6
723 myasthenia gravis 9.6
724 phenylketonuria 9.6
725 retinitis pigmentosa 9.6
726 rhabdomyosarcoma 2 9.6
727 short stature-obesity syndrome 9.6
728 sjogren syndrome 9.6
729 canavan disease 9.6
730 hypothyroidism, congenital, nongoitrous, 4 9.6
731 werner syndrome 9.6
732 xeroderma pigmentosum, complementation group c 9.6
733 xeroderma pigmentosum, complementation group d 9.6
734 adrenoleukodystrophy 9.6
735 body mass index quantitative trait locus 11 9.6
736 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.6
737 wiskott-aldrich syndrome 9.6
738 arts syndrome 9.6
739 tubulin, beta 9.6
740 rett syndrome 9.6
741 taqi polymorphism 9.6
742 prostatic hyperplasia, benign 9.6
743 helicobacter pylori infection 9.6
744 aminopterin syndrome sine aminopterin 9.6
745 pituitary adenoma, prolactin-secreting 9.6
746 autoimmune lymphoproliferative syndrome 9.6
747 body mass index quantitative trait locus 9 9.6
748 convulsions, familial infantile, with paroxysmal choreoathetosis 9.6
749 macular degeneration, age-related, 1 9.6
750 dermatitis, atopic 9.6
751 body mass index quantitative trait locus 8 9.6
752 sickle cell anemia 9.6
753 lymphoma, non-hodgkin, familial 9.6
754 paragangliomas 3 9.6
755 abdominal obesity-metabolic syndrome 1 9.6
756 phace association 9.6
757 pancreatic cancer 1 9.6
758 creatinine clearance quantitative trait locus 9.6
759 lissencephaly 1 9.6
760 body mass index quantitative trait locus 4 9.6
761 body mass index quantitative trait locus 10 9.6
762 griscelli syndrome, type 2 9.6
763 anxiety 9.6
764 repressor of telomerase expression 1 9.6
765 myopathy, myosin storage, autosomal dominant 9.6
766 body mass index quantitative trait locus 7 9.6
767 heat-shock rna 1 9.6
768 retinitis pigmentosa 36 9.6
769 malaria 9.6
770 bone mineral density quantitative trait locus 8 9.6
771 ewing sarcoma 9.6
772 myd88 deficiency 9.6
773 body mass index quantitative trait locus 12 9.6
774 body mass index quantitative trait locus 14 9.6
775 multiple sclerosis 3 9.6
776 microvascular complications of diabetes 5 9.6
777 congenital lipomatous overgrowth, vascular malformations, and epidermal nevi 9.6
778 bone mineral density quantitative trait locus 15 9.6
779 d-2-hydroxyglutaric aciduria 2 9.6
780 cyanosis, transient neonatal 9.6
781 beta-thalassemia 9.6
782 barrett esophagus 9.6
783 graft-versus-host disease 9.6
784 pontine tegmental cap dysplasia 9.6
785 schuurs-hoeijmakers syndrome 9.6
786 estrogen resistance 9.6
787 body mass index quantitative trait locus 18 9.6
788 myopathy, tubular aggregate, 2 9.6
789 thrombocytopenia 5 9.6
790 trichothiodystrophy 3, photosensitive 9.6
791 thrombocytopenia 6 9.6
792 chorea, childhood-onset, with psychomotor retardation 9.6
793 body mass index quantitative trait locus 19 9.6
794 fetal akinesia deformation sequence 2 9.6
795 body mass index quantitative trait locus 20 9.6
796 deficiency anemia 9.6
797 west syndrome 9.6
798 tick-borne encephalitis 9.6
799 lambert-eaton myasthenic syndrome 9.6
800 ophthalmomyiasis 9.6
801 lissencephaly 9.6
802 2-hydroxyglutaric aciduria 9.6
803 autosomal recessive disease 9.6
804 anaplastic large cell lymphoma 9.6
805 marginal zone b-cell lymphoma 9.6
806 paraganglioma 9.6
807 cervical dystonia 9.6
808 oculogyric crisis 9.6
809 hemidystonia 9.6
810 hemorrhagic cystitis 9.6
811 tongue squamous cell carcinoma 9.6
812 oral squamous cell carcinoma 9.6
813 fibroma 9.6
814 gastrointestinal carcinoma 9.6
815 withdrawal disorder 9.6
816 sexual disorder 9.6
817 connective tissue benign neoplasm 9.6
818 amusia 9.6
819 organic acidemia 9.6
820 adams-oliver syndrome 9.6
821 stuttering 9.6
822 persistent hyperplastic primary vitreous 9.6
823 autosomal recessive non-syndromic intellectual disability 9.6
824 cervical polyp 9.6
825 griscelli syndrome 9.6
826 primary microcephaly 9.6
827 ocular tuberculosis 9.6
828 bone disease 9.6
829 childhood acute lymphocytic leukemia 9.6
830 cryptococcal meningitis 9.6
831 hepatic veno-occlusive disease 9.6
832 mucolipidosis 9.6
833 myxofibrosarcoma 9.6
834 tongue carcinoma 9.6
835 hypogonadotropic hypogonadism 9.6
836 alpha thalassemia-x-linked intellectual disability syndrome 9.6
837 trypanosomiasis 9.6
838 mumps 9.6
839 viral meningitis 9.6
840 chronic meningitis 9.6
841 bacterial infectious disease 9.6
842 charcot-marie-tooth disease 9.6
843 primary optic atrophy 9.6
844 thrombotic thrombocytopenic purpura 9.6
845 filariasis 9.6
846 japanese encephalitis 9.6
847 hand, foot and mouth disease 9.6
848 tooth disease 9.6
849 strongyloidiasis 9.6
850 spastic diplegia 9.6
851 discitis 9.6
852 myiasis 9.6
853 chorioretinal scar 9.6
854 prostatic hypertrophy 9.6
855 neonatal respiratory failure 9.6
856 acute orbital inflammation 9.6
857 disseminated intravascular coagulation 9.6
858 microcytic anemia 9.6
859 cerebral arteritis 9.6
860 choroiditis 9.6
861 hemopericardium 9.6
862 suppurative otitis media 9.6
863 retinal vasculitis 9.6
864 listeria meningitis 9.6
865 cauda equina syndrome 9.6
866 scleral staphyloma 9.6
867 onchocerciasis 9.6
868 lyme disease 9.6
869 pericardial effusion 9.6
870 ischemic neuropathy 9.6
871 esophagitis 9.6
872 sympathetic ophthalmia 9.6
873 neurogenic bladder 9.6
874 graves' disease 9.6
875 dysentery 9.6
876 hepatic coma 9.6
877 blastomycosis 9.6
878 quadriplegia 9.6
879 choreatic disease 9.6
880 branch retinal artery occlusion 9.6
881 central retinal artery occlusion 9.6
882 acute cystitis 9.6
883 gout 9.6
884 typhoid fever 9.6
885 hepatic encephalopathy 9.6
886 optic disk drusen 9.6
887 sick sinus syndrome 9.6
888 polyneuropathy 9.6
889 schistosomiasis 9.6
890 rubeosis iridis 9.6
891 toxic shock syndrome 9.6
892 renal tubular acidosis 9.6
893 chronic purulent otitis media 9.6
894 neuronal ceroid lipofuscinosis 9.6
895 ectropion 9.6
896 thrombocytopenia due to platelet alloimmunization 9.6
897 endogenous depression 9.6
898 keratosis 9.6
899 benign breast phyllodes tumor 9.6
900 central nervous system tuberculosis 9.6
901 ventricular septal defect 9.6
902 pneumothorax 9.6
903 cystitis 9.6
904 heart septal defect 9.6
905 neuroendocrine tumor 9.6
906 vascular cancer 9.6
907 cheilitis 9.6
908 malignant fibrous histiocytoma 9.6
909 bardet-biedl syndrome 9.6
910 hyperostosis 9.6
911 brain germinoma 9.6
912 brain sarcoma 9.6
913 essential thrombocythemia 9.6
914 keratopathy 9.6
915 motor neuron disease 9.6
916 craniosynostosis 9.6
917 iron metabolism disease 9.6
918 acromegaly 9.6
919 retinal vascular disease 9.6
920 kluver-bucy syndrome 9.6
921 hematologic cancer 9.6
922 opiate dependence 9.6
923 capillary hemangioma 9.6
924 dyskeratosis congenita 9.6
925 bilirubin metabolic disorder 9.6
926 hairy cell leukemia 9.6
927 glucosephosphate dehydrogenase deficiency 9.6
928 endometrial adenocarcinoma 9.6
929 prostatic adenoma 9.6
930 endometriosis 9.6
931 cockayne syndrome 9.6
932 gallbladder cancer 9.6
933 cerebellopontine angle tumor 9.6
934 neurilemmoma of the fifth cranial nerve 9.6
935 neurilemmomatosis 9.6
936 tropical spastic paraparesis 9.6
937 teratocarcinoma 9.6
938 purpura 9.6
939 multifocal osteogenic sarcoma 9.6
940 chondroblastic osteosarcoma 9.6
941 optic nerve neoplasm 9.6
942 cellulitis 9.6
943 atypical choroid plexus papilloma 9.6
944 gestational trophoblastic neoplasm 9.6
945 skin disease 9.6
946 hermansky-pudlak syndrome 9.6
947 intraventricular meningioma 9.6
948 pleural empyema 9.6
949 chromophobe adenoma 9.6
950 medullomyoblastoma 9.6
951 childhood medulloblastoma 9.6
952 nodular medulloblastoma 9.6
953 lung squamous cell carcinoma 9.6
954 adrenal carcinoma 9.6
955 gastritis 9.6
956 mouth disease 9.6
957 liver disease 9.6
958 agnosia 9.6
959 cerebral neuroblastoma 9.6
960 syphilis 9.6
961 carcinosarcoma 9.6
962 radiculopathy 9.6
963 fibrous histiocytoma 9.6
964 central nervous system germinoma 9.6
965 seminoma 9.6
966 retrograde amnesia 9.6
967 unilateral retinoblastoma 9.6
968 uremia 9.6
969 perineurioma 9.6
970 medulloepithelioma 9.6
971 spinal cord astrocytoma 9.6
972 prosopagnosia 9.6
973 optic nerve astrocytoma 9.6
974 pineal parenchymal tumor of intermediate differentiation 9.6
975 liver cirrhosis 9.6
976 aortitis 9.6
977 ureteral obstruction 9.6
978 demyelinating polyneuropathy 9.6
979 blepharospasm 9.6
980 t-cell acute lymphoblastic leukemia 9.6
981 eye disease 9.6
982 chiasmal syndrome 9.6
983 retinal disease 9.6
984 gray zone lymphoma 9.6
985 malignant inflammatory fibrous histiocytoma 9.6
986 inflammatory breast carcinoma 9.6
987 overnutrition 9.6
988 angiomatous meningioma 9.6
989 inherited metabolic disorder 9.6
990 childhood pilocytic astrocytoma 9.6
991 t-cell lymphoblastic leukemia/lymphoma 9.6
992 meningothelial meningioma 9.6
993 premenstrual tension 9.6
994 diverticulitis 9.6
995 muscular atrophy 9.6
996 adult spinal cord glioblastoma multiforme 9.6
997 petroclival meningioma 9.6
998 end stage renal disease 9.6
999 mixed astrocytoma-ependymoma 9.6
1000 hyperthyroidism 9.6
1001 sporadic breast cancer 9.6
1002 congenital fibrosarcoma 9.6
1003 retinal degeneration 9.6
1004 influenza 9.6
1005 retinal artery occlusion 9.6
1006 mucormycosis 9.6
1007 monocytic leukemia 9.6
1008 collagen disease 9.6
1009 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.6
1010 subacute delirium 9.6
1011 vascular dementia 9.6
1012 lupus erythematosus 9.6
1013 actinic keratosis 9.6
1014 neuromyelitis optica 9.6
1015 learning disability 9.6
1016 cowpox 9.6
1017 narcolepsy 9.6
1018 amyloidosis 9.6
1019 amebiasis 9.6
1020 viral infectious disease 9.6
1021 acute myocardial infarction 9.6
1022 allergic asthma 9.6
1023 hypertensive encephalopathy 9.6
1024 exposure keratitis 9.6
1025 congenital nystagmus 9.6
1026 irritable bowel syndrome 9.6
1027 hypotropia 9.6
1028 dacryocystocele 9.6
1029 albinism 9.6
1030 myotonic dystrophy 9.6
1031 gjb1 disorders: charcot marie tooth neuropathy and central nervous system phenotypes 9.6
1032 pafah1b1-associated lissencephaly/subcortical band heterotopia 9.6
1033 slc12a5-related epilepsy of infancy with migrating focal seizures 9.6
1034 sickle cell disease 9.6
1035 adrenomyeloneuropathy 9.6
1036 adult neuronal ceroid lipofuscinosis 9.6
1037 carcinoma showing thymus-like differentiation 9.6
1038 choroid plexus cyst 9.6
1039 chromosome 10q deletion 9.6
1040 chromosome 1p deletion 9.6
1041 chromosome 4p deletion 9.6
1042 dendritic cell tumor 9.6
1043 enchondroma 9.6
1044 foix chavany marie syndrome 9.6
1045 glucagonoma 9.6
1046 heavy metal poisoning 9.6
1047 htlv-1 associated myelopathy/tropical spastic paraparesis 9.6
1048 lentigo maligna melanoma 9.6
1049 leukemia, t-cell, chronic 9.6
1050 lymphosarcoma 9.6
1051 mast cell activation syndrome 9.6
1052 myelodysplastic syndrome with excess blasts 9.6
1053 nephrogenic systemic fibrosis 9.6
1054 neural crest tumor 9.6
1055 ocular neuromyotonia 9.6
1056 oral cancer 9.6
1057 ovarian epithelial cancer 9.6
1058 pediatric multiple sclerosis 9.6
1059 pituitary stalk interruption syndrome 9.6
1060 post-transplant lymphoproliferative disease 9.6
1061 post-traumatic epilepsy 9.6
1062 pseudo-turner syndrome 9.6
1063 pure autonomic failure 9.6
1064 retroperitoneal fibrosis 9.6
1065 rosai-dorfman disease 9.6
1066 soft tissue sarcoma 9.6
1067 spastic paraparesis 9.6
1068 syringobulbia 9.6
1069 testicular seminoma 9.6
1070 transverse myelitis 9.6
1071 cln4 disease 9.6
1072 pacs1 syndrome 9.6
1073 autonomic dysfunction 9.6
1074 brain and spinal tumors 9.6
1075 central cord syndrome 9.6
1076 chronic pain 9.6
1077 dysautonomia 9.6
1078 hypertonia 9.6
1079 intracranial cysts 9.6
1080 korsakoff's amnesic syndrome 9.6
1081 paraneoplastic syndromes 9.6
1082 persistent vegetative state 9.6
1083 spinal cord infarction 9.6
1084 eating reflex epilepsy 9.6
1085 audiogenic seizures 9.6
1086 paraneoplastic limbic encephalitis 9.6
1087 angioosteohypertrophic syndrome 9.6
1088 mixed germ cell tumor 9.6
1089 neurotrophic keratopathy 9.6
1090 extraventricular neurocytoma 9.6
1091 central nervous system embryonal tumor 9.6
1092 papillary tumor of the pineal region 9.6
1093 partial deletion of chromosome 10 9.6
1094 partial deletion of chromosome 19 9.6
1095 basal encephalocele 9.6
1096 somatomammotropinoma 9.6
1097 manganese poisoning 9.6
1098 alk-negative anaplastic large cell lymphoma 9.6
1099 cyanide poisoning 9.6
1100 clear cell papillary renal cell carcinoma 9.6
1101 avascular necrosis 9.6
1102 pneumococcal meningitis 9.6
1103 cancer-associated retinopathy 9.6
1104 acute liver failure 9.6
1105 nodular lymphocyte predominant hodgkin lymphoma 9.6
1106 chronic encephalitis 9.6
1107 thrombotic microangiopathy 9.6
1108 intestinal polyposis syndrome 9.6
1109 precursor t-cell acute lymphoblastic leukemia 9.6
1110 adenoid cystic carcinoma 9.6 PTEN MMP9 IDH1
1111 breast ductal carcinoma 9.4 PTEN MMP9

Graphical network of the top 20 diseases related to Glial Tumor:



Diseases related to Glial Tumor

Symptoms & Phenotypes for Glial Tumor

MGI Mouse Phenotypes related to Glial Tumor:

45 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.55 CA2 IDH1 MMP9 OLIG2 PTEN
2 respiratory system MP:0005388 9.35 CA2 IDH1 MMP9 OLIG2 PTEN
3 skeleton MP:0005390 9.02 CA2 IDH1 MMP9 OLIG2 PTEN

Drugs & Therapeutics for Glial Tumor

Drugs for Glial Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 559, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
2
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
3
Glutamic acid Approved, Nutraceutical Phase 4 56-86-0 33032
4 Anti-Anxiety Agents Phase 4
5 Excitatory Amino Acid Antagonists Phase 4
6 alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid Phase 4
7 Anesthetics Phase 4
8 Analgesics, Non-Narcotic Phase 4
9 Analgesics Phase 4
10 Hypnotics and Sedatives Phase 4
11 Adrenergic Agents Phase 4
12 Adrenergic alpha-Agonists Phase 4
13 Adrenergic Agonists Phase 4
14
Dextroamphetamine Approved, Illicit Phase 3 51-64-9 5826
15
Lenograstim Approved, Investigational Phase 3 135968-09-1
16
Thiotepa Approved, Investigational Phase 3 52-24-4 5453
17
Carmustine Approved, Investigational Phase 3 154-93-8 2578
18
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
19
Dalteparin Approved Phase 3 9005-49-6
20
Tinzaparin Approved Phase 3 9041-08-1, 9005-49-6 25244225
21
Somatostatin Approved, Investigational Phase 2, Phase 3 38916-34-6, 51110-01-1 53481605
22
Ondansetron Approved Phase 3 99614-02-5 4595
23
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
24
Trioxsalen Approved Phase 3 3902-71-4 5585
25
Donepezil Approved Phase 3 120014-06-4 3152
26
Thioguanine Approved Phase 3 154-42-7 2723601
27
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
28
chloroquine Approved, Investigational, Vet_approved Phase 3 54-05-7 2719
29
Ethanol Approved Phase 2, Phase 3 64-17-5 702
30
Disulfiram Approved Phase 2, Phase 3 97-77-8 3117
31
Copper Approved, Investigational Phase 2, Phase 3 7440-50-8 27099
32
Lomustine Approved, Investigational Phase 3 13010-47-4 3950
33
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
34
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
35
Irinotecan Approved, Investigational Phase 3 97682-44-5, 100286-90-6 60838
36
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
37
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
38
Etoposide Approved Phase 3 33419-42-0 36462
39
leucovorin Approved Phase 3 58-05-9 6006 143
40
Histamine Approved, Investigational Phase 3 51-45-6 774
41
Methotrexate Approved Phase 3 59-05-2, 1959-05-2 126941
42
Cyproheptadine Approved Phase 3 129-03-3 2913
43
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
44
Norepinephrine Approved Phase 3 51-41-2 439260
45
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
46
Vitamin C Approved, Nutraceutical Phase 3 50-81-7 5785 54670067
47
Ornithine Approved, Nutraceutical Phase 3 70-26-8, 3184-13-2 6262
48
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
49 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
50 Dianhydrogalactitol Investigational Phase 3 23261-20-3
51 Cola Phase 3
52 Heparin, Low-Molecular-Weight Phase 3
53 calcium heparin Phase 3
54 Liver Extracts Phase 3
55 Cholinergic Agents Phase 3
56 Fibrinolytic Agents Phase 3
57 Anticoagulants Phase 3
58 Anesthetics, General Phase 3
59 Anesthetics, Intravenous Phase 3
60 Emetics Phase 3
61 Dihematoporphyrin Ether Phase 3
62 Hematoporphyrin Derivative Phase 3
63 Ether Phase 3
64 Cholinesterase Inhibitors Phase 3
65 Hematoporphyrins Phase 3
66 Anesthetics, Inhalation Phase 3
67 Narcotics Phase 3
68 Analgesics, Opioid Phase 3
69 Amebicides Phase 3
70 Chloroquine diphosphate Phase 3 50-63-5
71 Antiprotozoal Agents Phase 3
72 Antiparasitic Agents Phase 3
73 Antimalarials Phase 3
74 Copper Supplement Phase 2, Phase 3
75 Endothelial Growth Factors Phase 2, Phase 3
76 Immunoglobulins, Intravenous Phase 2, Phase 3
77 Immunoglobulin G Phase 2, Phase 3
78 Anti-Infective Agents Phase 3
79 Immunologic Factors Phase 3
80 Immunosuppressive Agents Phase 3
81 Antimetabolites Phase 3
82 Mitogens Phase 3
83 Tubulin Modulators Phase 3
84 Antimitotic Agents Phase 3
85
Liposomal doxorubicin Phase 3 31703
86 Anti-Bacterial Agents Phase 3
87 Antibiotics, Antitubercular Phase 3
88 topoisomerase I inhibitors Phase 3
89 Psychotropic Drugs Phase 3
90 Antidepressive Agents Phase 3
91 Dopamine Agents Phase 3
92 Antirheumatic Agents Phase 3
93 Protective Agents Phase 3
94 Gastrointestinal Agents Phase 3